It remains in clinical trials
The extract of Gordonii and its active component, Gordonosides F, promoted glucose-dependent GLP-1 and insulin release, demonstrating a blood glucose-lowering action during the oral glucose tolerance test (OGTT)
Gastrointestinal (GI) side effects of retatrutide are similar to those of semaglutide and other GLP-1 medications
GLP-1s account for 23% of first line diabetes therapy in 2025 up from 3% in 2021 Since 2019, the American Diabetes Association (ADA) has revised its Standards of Care each year to expand the role of GLP-1 receptor agonists and SGLT2 inhibitors as first-line treatments for T2D 2
In absence of sufficient evidence, theres a possibility that the seal may fail and a filling would be required
Maximize your GLP-1 results Tracking and personalized insights for Ozempic, Wegovy, Mounjaro, and Zepbound users